Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Titan Biotech has informed the stock exchange that its trading window for dealing in company securities will remain closed from Thursday, January 1, 2026 until 48 hours after the declaration of unaudited standalone and consolidated financial results for Q3 and nine months ending December 31, 2025. The closure applies to all designated persons, their immediate relatives, and connected persons as per the company's insider trading code. The board meeting date to approve these quarterly results will be announced separately in due course.
This is a routine regulatory compliance filing. For retail investors, it signals that Q3 FY26 earnings results are approaching, during which insiders are restricted from trading. No direct impact on stock price is expected, but the upcoming results announcement could be a near-term catalyst.